ecosystem / people / nazanin-alavi
N

Nazanin Alavi

Co-founder & Chief Medical Officer, OPTT

Health techKingston

Nazanin Alavi is a psychiatrist in Kingston, Ontario and a co-founder of OPTT, the online psychotherapy platform she and Mohsen Omrani developed at Queen's University in 2018. She is the company's chief medical officer. At Queen's she is an associate professor of psychiatry, and she leads the university's Online Psychotherapy Lab.

Nazanin hasn’t spoken on a TechTO, TechVancouver or TechWaterloo stage. This profile is here because Nazanin co-founded OPTT, which appears in 1 talk in the archive.

Around the web ×2

Quick answers

Did Nazanin Alavi co-found OPTT?

Queen's Partnerships and Innovation reported on 2021-11-24 that OPTT "was co-developed by Nazanin Alavi, Assistant Professor, Psychiatry, and Mohsen Omrani, Adjunct Assistant Professor, Psychiatry, in 2018". A Newsfile Corp. release dated 2022-12-22 describes OPTT's AI work as based on the experience of "co-founder and Chief Medical Officer Dr Nazanin Alavi".

What is her role at OPTT today?

OPTT's team page at optt.health, checked 2026-09-19, lists Nazanin Alavi as Chief Medical Officer, alongside Chief Executive Officer Mohsen Omrani and Product Management Director Ali Omrani.

What does she do outside OPTT?

The Queen's University Department of Psychiatry faculty directory, checked 2026-09-19, lists her as an Associate Professor and describes her as a staff psychiatrist who is Co-Program Medical Director at Kingston Health Sciences Centre and Chair of the Division of Adult Psychiatry (Acute).

What has her AI work in the clinic produced?

Kingston Health Sciences Centre reported on 2025-05-06 that an AI-assisted triage system introduced by Dr. Alavi and her team in its Mental Health and Addiction Care program helped cut appointment wait times by more than 50 per cent between 2023 and 2024.

Suggest an edit
This is you? Claim this profileAsk to be removed
Know someone who belongs here? Suggest a profile
Maintained by TechTO · facts sourced and dated · last reviewed Sep 19, 2026